Synovial Sarcoma - Online Patient Support Group

Olaratumab(Lartruvo) with Pembrolizumab (Keytruda)

Lilly and Merck announced a new study combining Lartruvo and Keytruda:
https://investor.lilly.com/releasedetail.cfm?ReleaseID=1007544

The study combining Olaratumab (Lartruvo) and Pembrolizumab (Keytruda) can be found here: